|
JP2002509858A
(ja)
*
|
1997-12-31 |
2002-04-02 |
ルトガーズ，ザ ステイト ユニバーシティ オブ ニュージャージー |
複素環式トポイソメラーゼ毒化合物
|
|
US6063801A
(en)
*
|
1998-02-12 |
2000-05-16 |
Rutgers, The State University Of New Jersey |
Heterocyclic topoisomerase poisons
|
|
WO2000076556A2
(en)
*
|
1999-06-11 |
2000-12-21 |
Neorx Corporation |
High dose radionuclide complexes for bone marrow suppression
|
|
US7094885B2
(en)
*
|
1999-07-11 |
2006-08-22 |
Neorx Corporation |
Skeletal-targeted radiation to treat bone-associated pathologies
|
|
US6740650B2
(en)
|
1999-10-29 |
2004-05-25 |
Rutgers, The State University Of New Jersey |
Heterocyclic cytotoxic agents
|
|
EP1390081A2
(en)
|
2001-01-08 |
2004-02-25 |
Neorx Corporation |
Therapeutic and diagnostic compounds, compositions, and methods
|
|
DE60235287D1
(de)
*
|
2001-11-14 |
2010-03-25 |
Univ Rutgers |
Löslich gemachte topoisomerase-gifte
|
|
MXPA04004607A
(es)
*
|
2001-11-14 |
2004-09-10 |
Univ Rutgers |
Agentes de venenos de topoisomerasa solubilizados.
|
|
EP1453812B1
(en)
*
|
2001-11-14 |
2008-08-20 |
Rutgers, The State University |
Cytotoxic agents
|
|
AU2002364953A1
(en)
*
|
2001-11-14 |
2003-06-17 |
Edmond J. Lavoie |
Topoisomerase poison agents
|
|
EP1458416A1
(en)
|
2001-12-13 |
2004-09-22 |
Dow Global Technologies Inc. |
Treatment of osteomyelitis with radiopharmaceuticals
|
|
AU2003268075A1
(en)
*
|
2002-08-09 |
2004-02-25 |
Edmond J. Lavoie |
Nitro and amino substituted dibenzonaphthyridines as topoisomerase agents
|
|
US6992088B2
(en)
*
|
2002-08-09 |
2006-01-31 |
Rutgers, The State University Of New Jersey |
Nitro and amino substituted heterocycles as topoisomerase I targeting agents
|
|
US6989387B2
(en)
*
|
2002-08-09 |
2006-01-24 |
Rutgers, The State University Of New Jersey |
Nitro and amino substituted topoisomerase agents
|
|
CA2510337C
(en)
*
|
2002-11-12 |
2013-01-08 |
Rutgers, The State University Of New Jersey |
Topoisomerase-targeting agents
|
|
GB0619325D0
(en)
|
2006-09-30 |
2006-11-08 |
Univ Strathclyde |
New compounds
|
|
GB0821913D0
(en)
|
2008-12-02 |
2009-01-07 |
Price & Co |
Antibacterial compounds
|
|
DK2403856T3
(da)
|
2009-03-06 |
2013-04-08 |
Univ Rutgers |
Methylendioxybenzo[i]phenanthridinderivater anvendt til behandling af cancer
|
|
WO2010127363A1
(en)
|
2009-05-01 |
2010-11-04 |
Rutgers, The State University Of New Jersey |
Toposiomerase inhibitors
|
|
ES2568455T3
(es)
*
|
2010-06-01 |
2016-04-29 |
Summit Therapeutics Plc |
Compuestos para el tratamiento de enfermedad asociada a Clostridium difficile
|
|
WO2015042438A1
(en)
*
|
2013-09-19 |
2015-03-26 |
The Florida International Board Of Trustees Modesto A. Maidique Campus |
Selective inhibition of bacterial topoisomerase i
|
|
GB201506660D0
(en)
|
2015-04-20 |
2015-06-03 |
Cellcentric Ltd |
Pharmaceutical compounds
|
|
GB201506658D0
(en)
|
2015-04-20 |
2015-06-03 |
Cellcentric Ltd |
Pharmaceutical compounds
|
|
US11434227B2
(en)
|
2016-01-23 |
2022-09-06 |
Vibha TANDON |
Broad spectrum antibacterial activity of novel bisbenzimidazoles targeting topoisomerase IA and the synergistic composition of bisbenzimidazole with efflux pump inhibitors against pathogenic bacteria
|
|
US11091498B2
(en)
|
2016-04-04 |
2021-08-17 |
Rutgers, The State University Of New Jersey |
Topoisomerase poisons
|
|
JP7267563B2
(ja)
|
2017-06-27 |
2023-05-02 |
株式会社Kyulux |
発光材料、化合物、遅延蛍光体および発光素子
|
|
WO2019004254A1
(ja)
|
2017-06-27 |
2019-01-03 |
株式会社Ｋｙｕｌｕｘ |
発光材料、化合物、遅延蛍光体および発光素子
|